NELFA
Basic information
Region (hg38): 4:1982717-2041903
Previous symbols: [ "WHSC2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NELFA gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 26 | 31 | ||||
missense | 25 | 33 | ||||
nonsense | 0 | |||||
start loss | 1 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 2 | ||||
non coding | 3 | |||||
Total | 0 | 0 | 26 | 34 | 8 |
Variants in NELFA
This is a list of pathogenic ClinVar variants found in the NELFA region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-1983359-G-A | not specified | Uncertain significance (Jun 26, 2023) | ||
4-1983411-T-C | not specified | Uncertain significance (Jul 02, 2024) | ||
4-1983432-C-A | not specified | Likely benign (Apr 07, 2023) | ||
4-1983477-C-T | not specified | Uncertain significance (Sep 06, 2022) | ||
4-1983478-G-T | not specified | Uncertain significance (Apr 04, 2024) | ||
4-1983636-G-A | Likely benign (Oct 24, 2018) | |||
4-1983642-C-T | Likely benign (May 01, 2023) | |||
4-1983663-G-A | Benign/Likely benign (Oct 01, 2023) | |||
4-1983860-G-A | Benign (Aug 01, 2023) | |||
4-1983891-T-C | not specified | Uncertain significance (Sep 20, 2023) | ||
4-1983899-C-T | Likely benign (May 30, 2018) | |||
4-1983918-G-A | not specified | Uncertain significance (Oct 20, 2024) | ||
4-1983940-C-T | not specified | Likely benign (Oct 20, 2023) | ||
4-1983941-G-A | Benign (Dec 31, 2019) | |||
4-1983948-G-A | not specified | Uncertain significance (Aug 30, 2021) | ||
4-1983980-C-T | Likely benign (Jan 19, 2018) | |||
4-1983984-G-A | not specified | Uncertain significance (Jan 19, 2024) | ||
4-1983990-G-A | Likely benign (Dec 31, 2019) | |||
4-1983991-T-G | not specified | Uncertain significance (Dec 28, 2023) | ||
4-1983994-G-C | not specified | Uncertain significance (Jul 09, 2021) | ||
4-1983999-G-A | not specified | Uncertain significance (Aug 08, 2023) | ||
4-1984029-G-A | not specified | Uncertain significance (Oct 29, 2021) | ||
4-1984032-C-T | not specified | Uncertain significance (Sep 30, 2024) | ||
4-1984046-C-T | Likely benign (Jan 11, 2018) | |||
4-1984047-G-A | not specified | Uncertain significance (Aug 27, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NELFA | protein_coding | protein_coding | ENST00000382882 | 11 | 59190 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.135 | 0.865 | 125735 | 0 | 13 | 125748 | 0.0000517 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.82 | 256 | 352 | 0.727 | 0.0000227 | 3417 |
Missense in Polyphen | 55 | 109.49 | 0.50234 | 975 | ||
Synonymous | -2.17 | 213 | 176 | 1.21 | 0.0000137 | 1142 |
Loss of Function | 3.29 | 6 | 23.0 | 0.260 | 0.00000124 | 256 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000906 | 0.0000906 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.000144 | 0.000139 |
European (Non-Finnish) | 0.0000638 | 0.0000615 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Essential component of the NELF complex, a complex that negatively regulates the elongation of transcription by RNA polymerase II. The NELF complex, which acts via an association with the DSIF complex and causes transcriptional pausing, is counteracted by the P-TEFb kinase complex. The NELF complex is involved in HIV-1 latency possibly involving recruitment of PCF11 to paused RNA polymerase II. In vitro, the NELFA:NELFCD subcomplex binds to ssDNA and ssRNA in a sequence- and structure-dependent manner. Probably required to interact with the RNA polymerase II complex. {ECO:0000269|PubMed:10199401, ECO:0000269|PubMed:12563561, ECO:0000269|PubMed:12612062, ECO:0000305}.;
- Pathway
- Initiation of transcription and translation elongation at the HIV-1 LTR;Disease;Formation of the HIV-1 Early Elongation Complex;Gene expression (Transcription);Formation of HIV-1 elongation complex containing HIV-1 Tat;Tat-mediated elongation of the HIV-1 transcript;Abortive elongation of HIV-1 transcript in the absence of Tat;HIV Transcription Elongation;HIV elongation arrest and recovery;Formation of HIV elongation complex in the absence of HIV Tat;Pausing and recovery of HIV elongation;Generic Transcription Pathway;Tat-mediated HIV elongation arrest and recovery;Pausing and recovery of Tat-mediated HIV elongation;Transcription of the HIV genome;Late Phase of HIV Life Cycle;HIV Life Cycle;HIV Infection;RNA Polymerase II Pre-transcription Events;Formation of RNA Pol II elongation complex ;RNA Polymerase II Transcription;Infectious disease;RNA Polymerase II Transcription Elongation;TP53 Regulates Transcription of DNA Repair Genes;Transcriptional Regulation by TP53;Formation of the Early Elongation Complex
(Consensus)
Recessive Scores
- pRec
- 0.146
Intolerance Scores
- loftool
- rvis_EVS
- -1.11
- rvis_percentile_EVS
- 6.83
Haploinsufficiency Scores
- pHI
- 0.160
- hipred
- Y
- hipred_score
- 0.780
- ghis
- 0.615
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- gene_indispensability_score
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nelfa
- Phenotype
Gene ontology
- Biological process
- transcription by RNA polymerase II;transcription elongation from RNA polymerase II promoter;multicellular organism development;negative regulation of transcription elongation from RNA polymerase II promoter
- Cellular component
- nucleoplasm;cytosol;nuclear body;NELF complex
- Molecular function
- protein binding